CIK 0001446847 · Accelerated filer<br>Smaller reporting company
IRONWOOD PHARMACEUTICALS INC
Sign in to watch- Ticker
- IRWD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043404176
- Phone
- 617-621-7722
- Business address
- 100 SUMMER STREET, SUITE 2300, BOSTON, MA, 02110
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-18 | Currie Mark G Director | Grant or award | +24,311 | 568,419 | ||
| 2024-06-15 | DENNER ALEXANDER J Director | Grant or award | +2,572 | 124,511 | ||
| 2024-06-10 | McHugh Julie Director | Sale 10b5-1 | −22,766 | $6.29 | $143K | 139,528 |
| 2024-06-07 | Moukheibir Catherine Director | Sale | −35,574 | $6.61 | $235K | 48,633 |
| 2024-06-06 | Moukheibir Catherine Director | Sale | −44,426 | $6.36 | $283K | 84,207 |
| 2024-05-20 | MCCOURT Thomas A Chief Executive Officer | Sale | −67,618 | $6.45 | $436K | 1,150,330 |
| 2024-05-20 | Davis Andrew SVP, Chief Business Officer | Sale | −22,725 | $6.45 | $147K | 288,031 |
| 2024-05-20 | Shetzline Michael CMO,SVP,Head-Res&Drug | Sale | −16,128 | $6.45 | $104K | 413,719 |
| 2024-05-20 | John Minardo Chief Legal Officer | Sale | −17,404 | $6.45 | $112K | 294,571 |
| 2024-05-16 | Emany Sravan Kumar SVP, Chief Financial Officer | Shares withheld for taxes | −18,280 | $6.64 | $121K | 320,573 |
| 2024-03-15 | DENNER ALEXANDER J Director | Grant or award | +1,662 | 121,939 | ||
| 2024-03-08 | Davis Andrew SVP, Chief Business Officer | Option exercise | +37,120 | 310,756 | ||
| 2024-03-08 | Davis Andrew SVP, Chief Business Officer | Option exercise · Performance-based Restricted Stock Unit | −37,120 | 0 | ||
| 2024-03-08 | MCCOURT Thomas A Chief Executive Officer | Option exercise | +120,298 | 1,217,948 | ||
| 2024-03-08 | MCCOURT Thomas A Chief Executive Officer | Option exercise · Performance-based Restricted Stock Unit | −120,298 | 0 | ||
| 2024-03-08 | John Minardo Chief Legal Officer | Option exercise | +32,752 | 311,975 | ||
| 2024-03-08 | John Minardo Chief Legal Officer | Option exercise · Performance-based Restricted Stock Unit | −32,752 | 0 | ||
| 2024-03-08 | Emany Sravan Kumar SVP, Chief Financial Officer | Option exercise | +37,120 | 338,853 | ||
| 2024-03-08 | Emany Sravan Kumar SVP, Chief Financial Officer | Option exercise · Performance-based Restricted Stock Unit | −37,120 | 0 | ||
| 2024-03-08 | Shetzline Michael CMO,SVP,Head-Res&Drug | Option exercise | +34,936 | 429,847 |
Page 5 of 7 · 128 trades